“Off-The-Shelf” Third Party T Cells for CAR-T Therapy Under Investigation | Cancer Network

See on Scoop.it - iMaritha

Using CRISPR/Cas9 gene editing to remove CD7 from healthy T cells, researchers have found a way to use third party T cells for CAR-T therapy in T-cell hematologic malignancies. 1

from Tumblr http://ift.tt/2DALre6
via IFTTT